Search Results - "NAGASAWA, Toshirou"

Clinical Application of ROBOT SUIT HAL® (Hybrid Assistive Limb®) for Rehabilitation Case Study by WATANABE, Hiroki, TANAKA, Naoki, KANAMORI, Takeshige, SAITOU, Hideyuki, NAGASAWA, Toshirou, KOSEKI, Susumu, SANKAI, Yoshiyuki, YANAGI, Hisako

“…[Purpose] The purpose of this study was to investigate the possibility of using a hybrid assistive limb® (HAL®) for clinical rehabilitation. [Subjects] Ten…”
Get full text

健常成人における歩行様式の違いによる脳内血液酸素動態の検討 by 内藤, 幾愛, 斉藤, 秀之, 柳, 久子, 矢野, 博明, 長澤, 俊郎, 小関, 迪

Get full text

The Dynamics of Blood Oxygen in the Brain of Healthy Young Adults in the Performance of Various Walking Styles by NAITOU, Ikue, SAITOU, Hideyuki, YANAGI, Hisako, YANO, Hiroaki, NAGASAWA, Toshirou, KOSEKI, Susumu

“…[Purpose] The objectives of this study were to investigate the dynamics of blood oxygen in the brain in the performance of various walking styles. [Subjects]…”
Get full text

Clinical Application of ROBOT SUIT HAL super( registered ) (Hybrid Assistive Limb super( registered )) for Rehabilitation Case Study by Watanabe, Hiroki, Tanaka, Naoki, Kanamori, Takeshige, Saitou, Hideyuki, Nagasawa, Toshirou, Koseki, Susumu, Sankai, Yoshiyuki, Yanagi, Hisako

“…Purpose: The purpose of this study was to investigate the possibility of using a hybrid assistive limb super( registered ) (HAL super( registered )) for…”
Get full text

255. Potent Cancer Immunotherapy with Dendritic Cells Generated from Genetically Modified Hematopoietic Stem Cells by Nabekura, Tsukasa, Nakauchi, Hiromitsu, Nagasawa, Toshirou, Onodera, Masafumi

“…Since dendritic cells (DCs) genetically engineered to express tumor-associated antigens (TAAs) can elicit potent anti-tumor immunity, cancer immunotherapy with…”
Get full text

Clinicopathological study of 6 cases of mantle zone lymphoma by Shibuya, A, Muraki, Y, Satoh, Y, Kobayashi, T, Kojima, H, Nagasawa, T, Abe, T, Tomiyama, J, Kudoh, H, Adachi, Y

“…Clinicopathological analyses of 6 cases of mantle zone lymphoma (MZL) were carried out. The median age of the patients was 62 years with a range of 41 to 71…”
Get more information

Childhood cyclic neutropenia treated with recombinant human granulocyte colony stimulating factor by Hanada, T, Ono, I, Nagasawa, T

Get more information